I spoke yesterday with Josef Woodman, author of Patients Beyond Borders: Everybody’s Guide to Affordable, World-Class Medical Tourism. Listen in and hear what he has to say.
Drug safety is a big issue these days. FDA has been criticized for allowing drugs with safety problems to reach the market. Merck is embroiled in thousands of lawsuits over heart problems allegedly caused by Vioxx. And not a month goes by without the cardiac safety profile of a marketed drug being questioned. Yesterday, the Senate passed a bill granting the FDA greater authority to restrict the use of drugs when safety problems are discovered after launch.
I recently joined the board of iCardiac Technologies, a startup company which is developing new tests that use ECGs to find cardiac safety problem with drugs early in development. iCardiac has already signed a research alliance with Pfizer and attracted investment from venture capitalists.
I visited the company today and spoke with its Chairman and CEO, Mike Totterman. Listen in and hear what he has to say.
Physicians Interactive, a business unit of electronic health record company Allscripts, is developing interactive portals to help pharmaceutical companies augment the reach of their traditional sales forces. Physicians can log on for “e-details,” request product samples, and gain access to patient and professional education materials.
In this podcast I interview Physicians Interactive’s president, Donato Tramuto. We discuss the evolving relationship between pharma companies and physicians, the impact of evidence based medicine, and the roles of consumers and health plans.
Using the example of his own asthma, Donato contends that there is no inherent conflict between pharmaceutical company sales objectives, patient well-being and cost effectiveness.
Listen in and see what you think.